Table 4. Univariate and multivariable analysis of prognostic factors in IDC patients for 5-year survival.
| Variable | Univariate analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
| HR | P > |z| | 95% CI | HR | P > |z| | 95% CI | |
| Age (yr) | ||||||
| < 55 vs. ≥ 55 | 1.371 | 0.320 | 0.736–2.553 | |||
| Pathology typing | ||||||
| I vs. II –III | 0.829 | 0.692 | 0.327–2.102 | |||
| Tumor size (cm) | ||||||
| < 2 vs. ≥ 2 | 1.224 | 0.614 | 0.559–2.678 | |||
| Axillary lymph node | ||||||
| N0 vs. NX | 1.060 | 0.858 | 0.561–2.001 | |||
| ER expression | ||||||
| Positive vs. Negative | 1.480 | 0.448 | 0.538–4.069 | |||
| PR expression | ||||||
| Positive vs. Negative | 1.571 | 0.361 | 0.596–4.142 | |||
| Her-2 expression | ||||||
| Positive vs. Negative | 2.805 | 0.006 | 1.337–5.885 | 2.588 | 0.008 | 1.277–5.246 |
| Ki-67 expression | ||||||
| High vs. Low | 0.455 | 0.015 | 0.240–0.859 | 0.492 | 0.022 | 0.269–0.901 |
| Molecular typing | ||||||
| Luminal A vs. Luminal B vs. Her-2 positive vs. Basal-like | 1.725 | 0.019 | 1.096–2.714 | 1.314 | 0.052 | 0.998–1.730 |
| PRSS3 expression | ||||||
| High vs. Low | 0.346 | 0.007 | 0.159–0.752 | 0.372 | 0.009 | 0.178–0.781 |